Tuesday , October 17 2017
Home / Letter From The Editor / Editor’s Note, SGLT-2 Inhibitors Special Edition, August 2015

Editor’s Note, SGLT-2 Inhibitors Special Edition, August 2015

On Wednesday night, I was in Beverly Hills and was able to sit in on a presentation that a cardiologist was providing to a group of nurse practitioners and physician assistants. He was talking about cutting down salt as an easy-to-follow method to reduce blood pressure. One of the attendees asked if sugar has an affect on blood pressure as well. The physician did not have an answer, but Dr. George Bakris does in his interview with Steve Freed.
 
For years, the starting point of type 2 diabetes has been metformin, and if for some reason your patient can’t tolerate metformin, then a sulphonylurea would be the choice. Now there is a study showing that canaglifozin could be used as a mono therapy with good success.